| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17, 2023 | RMD Resmed Inc | Douglas Robert Andrew71 | President And COO | Sell | 1,500 | $224.65 | $336,975.00 | -0.6% | -2.1% | -18.0% | |
| Apr 17, 2023 | DXCM Dexcom Inc | Flynn Paul R47 | EVP Global Revenue | Sell | 2,781 | $120.00 | $333,720.00 | -5.1% | +15.8% | +15.1% | |
| Apr 14, 2023 | BLFS Biolife Solutions Inc | Schulz Marcus71 | Chief Revenue Officer | Sell | 215 | $21.05 | $4,525.75 | -0.5% | +3.1% | -17.0% | |
| Apr 14, 2023 | STSS Sharps Technology Inc. | Hayes Robert Michael | Chief Executive Officer | Buy | 4,000 | $1.28 | $5,120.00 | +6.5% | -30.6% | -71.5% | |
| Apr 14, 2023 | EW Edwards Lifesciences Corp | Mussallem Michael A65 | Chairman &CEO | Sell | 19,875 | $84.20 | $1,673,433.66 | -11.9% | +10.3% | +7.0% | |
| Apr 12, 2023 | TMCI Treace Medical Concepts, Inc. | Bays F Barry80 | Director | Sell | 86,160 | $26.27 | $2,263,498.71 | -2.4% | -11.8% | -51.3% | |
| Apr 12, 2023 | MXCT Maxcyte, Inc. | Ross Thomas M.82 | EVP, Global Sales &Marketing | Sell | 14,134 | $5.00 | $70,670.00 | -100% | -2.3% | -20.1% | |
| Apr 12, 2023 | MXCT Maxcyte, Inc. | Doerfler Douglas81 | President And CEO | Sell | 15,000 | $5.00 | $75,000.00 | -1.5% | -2.3% | -20.1% | |
| Apr 11, 2023 | ICUI Icu Medical Inc/de | Sanzone Virginia Ruth64 | VP, General Counsel | Sell | 250 | $175.00 | $43,750.00 | -5.1% | +0.6% | -43.1% | |
| Apr 11, 2023 | AVTR Avantor, Inc. | Couturier Christophe75 | EVP, Amea | Sell | 1,498 | $21.18 | $31,727.64 | -1.5% | -4.0% | +18.7% | |
| Apr 11, 2023 | PRCT Procept Biorobotics Corp | Shiblaq Hisham55 | EVP, Chief Comm. Officer | Sell | 21,930 | $35.23 | $772,514.95 | -41.1% | +9.4% | +47.2% | |
| Apr 11, 2023 | RBOT Vicarious Surgical Inc. | Liang Philip45 | Director | Buy | 17,002 | $2.26 | $38,407.52 | +2.4% | -25.2% | -86.3% | |
| Apr 10, 2023 | CTKB Cytek Biosciences, Inc. | Jiang Wenbin75 | President And CEO | Sell | 20,000 | $8.88 | $177,600.00 | -0.3% | -1.3% | -23.1% | |
| Apr 10, 2023 | DXCM Dexcom Inc | Stern Sadie72 | EVP Chief Human Resources Offi | Sell | 393 | $112.35 | $44,153.55 | -0.5% | +16.1% | +24.8% | |
| Apr 10, 2023 | RBOT Vicarious Surgical Inc. | Liang Philip45 | Director | Buy | 5,925 | $2.20 | $13,035.00 | New | -19.5% | -84.6% | |
| Apr 10, 2023 | IRMD Iradimed Corp | Susi Roger E.53 | President, CEO And Chairman | Sell | 10,000 | $40.26 | $402,577.00 | -1.8% | +15.2% | +1.9% | |
| Apr 6, 2023 | TMCI Treace Medical Concepts, Inc. | Mott Richard W81 | Director | Sell | 4,043 | $26.00 | $105,121.23 | -0.4% | -13.1% | -56.8% | |
| Apr 6, 2023 | BLFS Biolife Solutions Inc | Rice Michael72 | CEO | Sell | 3,214 | $20.03 | $64,376.42 | -0.7% | +1.3% | -14.9% | |
| Apr 6, 2023 | BLFS Biolife Solutions Inc | Berard Todd67 | Chief Marketing Officer | Sell | 1,545 | $20.03 | $30,946.35 | -1.3% | +1.3% | -14.9% | |
| Apr 6, 2023 | BLFS Biolife Solutions Inc | Foster Karen A.68 | Chief Quality Officer | Sell | 1,101 | $20.03 | $22,053.03 | -0.9% | +1.3% | -14.9% | |
| Apr 6, 2023 | EW Edwards Lifesciences Corp | Lemercier Jean-Luc M67 | Cvp, Emeacla And Japac | Sell | 6,640 | $83.10 | $551,766.07 | -3.8% | +8.4% | +10.5% | |
| Apr 6, 2023 | BLFS Biolife Solutions Inc | Schulz Marcus71 | Chief Revenue Officer | Sell | 771 | $20.03 | $15,443.13 | -1.8% | +1.3% | -14.9% | |
| Apr 6, 2023 | BLFS Biolife Solutions Inc | Aebersold Sarah60 | Chief Human Resources Officer | Sell | 739 | $20.03 | $14,802.17 | -1.7% | +1.3% | -14.9% | |
| Apr 6, 2023 | RBOT Vicarious Surgical Inc. | Liang Philip45 | Director | Buy | 3,000 | $2.05 | $6,150.00 | +0.4% | -11.3% | -87.1% | |
| Apr 6, 2023 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 6,725 | $83.09 | $558,801.10 | -9.7% | +8.4% | +10.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.